Want to see ZSTK full AI Analyst Report?
ZSTK Stock Chart & Stats
$6.47
-$0.10(-6.90%)
At close: 4:00 PM EDT
$6.47
-$0.10(-6.90%)
Day’s Range― - ―
52-Week Range$1.32 - $47.00
Previous CloseN/A
Volume5.97K
Average Volume (3M)947.16K
Market Cap
$93.83M
Enterprise Value$29.68
Total Cash (Recent Filing)$2.96M
Total Debt (Recent Filing)$2.76M
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Nov 11, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-120.27
Shares Outstanding21,820,526
10 Day Avg. Volume224,759
30 Day Avg. Volume947,165
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.24
Price to Sales (P/S)0.48
P/FCF Ratio-1.96
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.65
Revenue Forecast (FY)$29.50M
Bulls Say, Bears Say
Bulls Say
Moderate LeverageModerate leverage limits immediate balance-sheet stress and may preserve financing flexibility. However, this benefit depends on stabilizing operations because ongoing losses and asset contraction could erode the current capital base.
Business DiversificationOperating across digital assets, AI and pharmaceutical distribution could broaden revenue exposure and reduce reliance on one business line. The established wholesale footprint may provide a non-crypto operating anchor as the corporate strategy evolves.
Strategic AI And Blockchain ExpansionThe repositioning creates exposure to emerging decentralized AI infrastructure and blockchain applications, potentially opening a new strategic growth platform. Its durability depends on execution, adoption, custody controls and regulatory acceptance.
Bears Say
Severe Revenue And Profitability DeteriorationThe sharp revenue contraction and negative gross profit indicate that the core operating model is currently failing to cover delivery costs. Extreme operating and net losses undermine earnings quality and raise substantial doubts about sustainable scalability.
Persistent Cash BurnContinued cash consumption means the business is not funding operations internally and may require external capital or asset monetization. Worsening free cash flow reduces resilience and limits the ability to invest in durable growth.
Crypto And Governance RiskConcentrating the business around crypto assets exposes results to volatility, custody, accounting and regulatory risks. Expanded equity plans and share issuance can further dilute holders and increase governance complexity during the transition.
ZeroStack News
ZSTK FAQ
What was ZeroStack’s price range in the past 12 months?
ZeroStack lowest stock price was $1.32 and its highest was $47.00 in the past 12 months.
What is ZeroStack’s market cap?
ZeroStack’s market cap is $93.83M.
When is ZeroStack’s upcoming earnings report date?
ZeroStack’s upcoming earnings report date is Nov 11, 2026 which is in 66 days.
How were ZeroStack’s earnings last quarter?
ZeroStack released its earnings results on Jul 31, 2026. The company reported -$2.47 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$2.36.
Is ZeroStack overvalued?
According to Wall Street analysts ZeroStack’s price is currently Overvalued.
Does ZeroStack pay dividends?
ZeroStack does not currently pay dividends.
What is ZeroStack’s EPS estimate?
ZeroStack’s EPS estimate is -0.12.
How many shares outstanding does ZeroStack have?
ZeroStack has 21,820,526 shares outstanding.
What happened to ZeroStack’s price movement after its last earnings report?
ZeroStack reported an EPS of -$2.47 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went up 13.816%.
Which hedge fund is a major shareholder of ZeroStack?
Currently, no hedge funds are holding shares in ZSTK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ZeroStack Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ZSTK Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $3.4M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-80.37%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
11.12%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ZeroStack
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Technical Analysis
cbdMD
―
China SXT Pharmaceuticals
―
Cosmos Holdings
―
IM Cannabis Corp
―
Incannex Healthcare Limited Sponsored ADR
―
Ownership Overview
49.82% Insiders
0.15% Mutual Funds
― Other Institutional Investors
49.91% Public Companies and
Individual Investors